Clinical implications of thrombocytopenia among patients undergoing intra-aortic balloon pump counterpulsation in the coronary care unit

Clinical Cardiology

Volumn 33, Issue 1, 2010, Pages 30-35

  Roy, Sion K ^a   Howard, Edward W ^a   Panza, Julio A ^b   Cooper, Howard A ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; ANTICOAGULATION; AORTA BALLOON; ARTICLE; BLEEDING; BODY WEIGHT; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY CARE UNIT; COUNTERPULSATION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION;

AGED; ANTICOAGULANTS; BODY WEIGHT; CONFIDENCE INTERVALS; CORONARY CARE UNITS; DISTRICT OF COLUMBIA; FEMALE; HEPARIN; HUMANS; INCIDENCE; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; ODDS RATIO; PLATELET COUNT; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOCYTOPENIA;

EID: 74949123474     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20694     Document Type: Article

References (12)

1. Bream-Rouwenhorst HR, Hobbs RA,Horwitz PA. Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. J Interv Cardiol. 2008;21(4):350-356.
2. Vonderheide RH, Thadhani R, Kuter DJ. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med. 1998;105(1):27-32.
3. McCabe JC, Abel RM, Subramanian VA, et al. Complications of intra-aortic balloon insertion and counterpulsation. Circulation. 1978;57(4):769-773.
4. Gore JM, Spencer FA, Gurfinkel EP, et al. Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2009;103(2):175-180.
5. Leinbach RC, Nyilas E, Caulfield JB, et al. Evaluation of hematologic effects of intra-aortic balloon assistance in man. Trans Am Soc Artif Intern Organs. 1972;18(0):493-500, 512.
6. Cooper HA, Thompson E, Panza JA. The role of heparin anticoagulation during intra-aortic balloon counterpulsation in the coronary care unit. Acute Card Care. 2008;10(4):214-220.
7. Moulopoulos SD, Topaz S, Kolff WJ. Diastolic balloon pumping (with carbon dioxide) in the aorta - a mechanical assistance to the failing circulation. Am Heart J. 1962;63:669-675.
8. Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203(2):113-118.
9. Bregman D, Nichols AB, Weiss MB, et al. Percutaneous intraaortic balloon insertion. Am J Cardiol. 1980;46(2):261-264.
10. Laish-Farkash A, Hod H, Matetzky S, et al. Safety of intra-aortic balloon pump using glycoprotein IIb/IIIa antagonists. Clin Cardiol. 2009;32(2):99-103.
11. Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol. 2006;97(9):1391-1398.
12. Jang IK, Hursting MJ.When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation. 2005;111(20): 2671-2683.